Fulgent Genetics Stock Buy Hold or Sell Recommendation

FLGT Stock  USD 21.70  0.01  0.05%   
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Fulgent Genetics is 'Hold'. Macroaxis provides Fulgent Genetics buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding FLGT positions. The advice algorithm takes into account all of Fulgent Genetics' available fundamental, technical, and predictive indicators you will find on this site. Key drivers impacting Fulgent Genetics' buy or sell advice are summarized below:
Real Value
25.92
Target Price
36.5
Hype Value
21.46
Market Value
21.7
Naive Value
22.41
A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Fulgent Genetics given historical horizon and risk tolerance towards Fulgent Genetics. When Macroaxis issues a 'buy' or 'sell' recommendation for Fulgent Genetics, the advice is generated through an automated system that utilizes algorithms and statistical models.
  
Check out Fulgent Genetics Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool.
For more information on how to buy Fulgent Stock please use our How to Invest in Fulgent Genetics guide.
In addition, we conduct extensive research on individual companies such as Fulgent and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Fulgent Genetics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price.

Execute Fulgent Genetics Buy or Sell Advice

The Fulgent recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Fulgent Genetics. Macroaxis does not own or have any residual interests in Fulgent Genetics or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Fulgent Genetics' advice using the current market data and latest reported fundamentals.

Time Horizon

Risk Tolerance

Execute Advice
Sell Fulgent GeneticsBuy Fulgent Genetics
Hold

Market Performance

Very WeakDetails

Volatility

Very steadyDetails

Hype Condition

Over hypedDetails

Current Valuation

UndervaluedDetails

Odds Of Distress

LowDetails

Economic Sensitivity

Hyperactively responds to market trendsDetails

Investor Sentiment

AlarmedDetails

Analyst Consensus

BuyDetails

Financial Strenth (F Score)

HealthyDetails

Financial Leverage

InapplicableDetails

Reporting Quality (M-Score)

Unlikely ManipulatorDetails
For the selected time horizon Fulgent Genetics has a Risk Adjusted Performance of (0.1), Jensen Alpha of (0.73), Total Risk Alpha of (1.00) and Treynor Ratio of (0.21)
Our investment recommendation module complements current analysts and expert consensus on Fulgent Genetics. It analyzes the firm potential to grow using all fundamental, technical, and market related data available at the time. To make sure Fulgent Genetics is not overpriced, please confirm all Fulgent Genetics fundamentals, including its debt to equity, market capitalization, and the relationship between the ebitda and earnings per share . Given that Fulgent Genetics has a price to earning of 3.95 X, we urge you to verify Fulgent Genetics market performance and probability of bankruptcy to ensure the company can sustain itself in the current economic cycle given your prevailing risk tolerance and investing horizon.

Fulgent Genetics Trading Alerts and Improvement Suggestions

Fulgent Genetics generated a negative expected return over the last 90 days
The company reported the previous year's revenue of 289.21 M. Net Loss for the year was (167.82 M) with profit before overhead, payroll, taxes, and interest of 366.9 M.
About 32.0% of the company shares are held by company insiders
Latest headline from MacroaxisInsider: Disposition of 865 shares by Paul Kim of Fulgent Genetics at 29.33 subject to Rule 16b-3

Fulgent Genetics Returns Distribution Density

The distribution of Fulgent Genetics' historical returns is an attempt to chart the uncertainty of Fulgent Genetics' future price movements. The chart of the probability distribution of Fulgent Genetics daily returns describes the distribution of returns around its average expected value. We use Fulgent Genetics price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Fulgent Genetics returns is essential to provide solid investment advice for Fulgent Genetics.
Mean Return
-0.45
Value At Risk
-4.73
Potential Upside
3.83
Standard Deviation
2.41
   Return Density   
       Distribution  
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Fulgent Genetics historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.

Fulgent Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Fulgent Genetics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Fulgent Genetics backward and forwards among themselves. Fulgent Genetics' institutional investor refers to the entity that pools money to purchase Fulgent Genetics' securities or originates loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares
Morgan Stanley - Brokerage Accounts2023-12-31
263.3 K
Ameriprise Financial Inc2023-12-31
250.6 K
Northern Trust Corp2023-12-31
231.4 K
Goldman Sachs Group Inc2023-12-31
204.8 K
Citadel Advisors Llc2023-09-30
193 K
Norges Bank2023-12-31
176.5 K
Bank Of New York Mellon Corp2023-12-31
155.9 K
Bridgeway Capital Management, Llc2023-12-31
153.7 K
Divisadero Street Capital Management, Lp2023-12-31
137.3 K
Blackrock Inc2023-12-31
3.8 M
Dimensional Fund Advisors, Inc.2023-12-31
1.4 M
Note, although Fulgent Genetics' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Fulgent Genetics Cash Flow Accounts

201920202021202220232024 (projected)
Investments(27.9M)(289.9M)(460.9M)(261.3M)38.9M40.8M
Change In Cash5.2M75.5M77.5M(85.4M)18.0M10.6M
Free Cash Flow4.2M104.1M514.7M234.7M4.8M4.6M
Depreciation2.1M3.0M11.0M32.7M31.8M33.3M
Other Non Cash Items1.5M8.0M16.0M43.5M105.8M111.1M
Capital Expenditures1.3M36.5M23.8M18.8M22.2M12.9M
Net Income(411K)214.3M506.2M141.9M(167.8M)(159.4M)
End Period Cash Flow12.0M87.4M164.9M79.5M97.5M50.9M
Change To Netincome4.2M8.7M22.9M75.5M86.8M91.1M
Change Receivables(2.0M)(839K)(178.5M)42.3M38.1M40.0M

Fulgent Genetics Greeks

Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Fulgent Genetics or Health Care Providers & Services sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Fulgent Genetics' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Fulgent stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α
Alpha over NYSE Composite
-0.73
β
Beta against NYSE Composite2.17
σ
Overall volatility
2.46
Ir
Information ratio -0.24

Fulgent Genetics Volatility Alert

Fulgent Genetics exhibits very low volatility with skewness of -0.22 and kurtosis of 1.0. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Fulgent Genetics' stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Fulgent Genetics' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.

Fulgent Genetics Fundamentals Vs Peers

Comparing Fulgent Genetics' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Fulgent Genetics' direct or indirect competition across all of the common fundamentals between Fulgent Genetics and the related equities. This way, we can detect undervalued stocks with similar characteristics as Fulgent Genetics or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Fulgent Genetics' fundamental indicators could also be used in its relative valuation, which is a method of valuing Fulgent Genetics by comparing valuation metrics with those of similar companies.
    
 Better Than Average     
    
 Worse Than Average Compare Fulgent Genetics to competition
FundamentalsFulgent GeneticsPeer Average
Return On Equity-0.15-0.31
Return On Asset-0.0347-0.14
Profit Margin(0.58) %(1.27) %
Operating Margin(0.47) %(5.51) %
Current Valuation235.34 M16.62 B
Shares Outstanding29.78 M571.82 M
Shares Owned By Insiders31.76 %10.09 %
Shares Owned By Institutions49.38 %39.21 %
Number Of Shares Shorted611.22 K4.71 M
Price To Earning3.95 X28.72 X
Price To Book0.57 X9.51 X
Price To Sales2.23 X11.42 X
Revenue289.21 M9.43 B
Gross Profit366.9 M27.38 B
EBITDA(43.54 M)3.9 B
Net Income(167.82 M)570.98 M
Cash And Equivalents515.4 M2.7 B
Cash Per Share17.03 X5.01 X
Total Debt14.91 M5.32 B
Debt To Equity0.03 %48.70 %
Current Ratio5.29 X2.16 X
Book Value Per Share38.31 X1.93 K
Cash Flow From Operations27 M971.22 M
Short Ratio1.93 X4.00 X
Earnings Per Share(5.63) X3.12 X
Price To Earnings To Growth1.32 X4.89 X
Target Price26.67
Number Of Employees1.18 K18.84 K
Beta1.45-0.15
Market Capitalization645.56 M19.03 B
Total Asset1.27 B29.47 B
Retained Earnings633.17 M9.33 B
Working Capital434.83 M1.48 B
Note: Disposition of 865 shares by Paul Kim of Fulgent Genetics at 29.33 subject to Rule 16b-3 [view details]

Fulgent Genetics Market Momentum

Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Fulgent . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.

About Fulgent Genetics Buy or Sell Advice

When is the right time to buy or sell Fulgent Genetics? Buying financial instruments such as Fulgent Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
 2021 2022 2023 2024 (projected)
Other Current Liabilities36.7M58.4M49.1M51.6M
Total Assets1.3B1.4B1.3B1.3B

Use Investing Ideas to Build Portfolios

In addition to having Fulgent Genetics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Industrials ETFs Thematic Idea Now

Industrials ETFs
Industrials ETFs Theme
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Industrials ETFs theme has 38 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Industrials ETFs Theme or any other thematic opportunities.
View All  Next Launch
When determining whether Fulgent Genetics is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Fulgent Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Fulgent Genetics Stock. Highlighted below are key reports to facilitate an investment decision about Fulgent Genetics Stock:
Check out Fulgent Genetics Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool.
For more information on how to buy Fulgent Stock please use our How to Invest in Fulgent Genetics guide.
Note that the Fulgent Genetics information on this page should be used as a complementary analysis to other Fulgent Genetics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.

Complementary Tools for Fulgent Stock analysis

When running Fulgent Genetics' price analysis, check to measure Fulgent Genetics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Fulgent Genetics is operating at the current time. Most of Fulgent Genetics' value examination focuses on studying past and present price action to predict the probability of Fulgent Genetics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Fulgent Genetics' price. Additionally, you may evaluate how the addition of Fulgent Genetics to your portfolios can decrease your overall portfolio volatility.
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Transaction History
View history of all your transactions and understand their impact on performance
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Is Fulgent Genetics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Fulgent Genetics. If investors know Fulgent will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Fulgent Genetics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.99)
Earnings Share
(5.63)
Revenue Per Share
9.71
Quarterly Revenue Growth
0.041
Return On Assets
(0.03)
The market value of Fulgent Genetics is measured differently than its book value, which is the value of Fulgent that is recorded on the company's balance sheet. Investors also form their own opinion of Fulgent Genetics' value that differs from its market value or its book value, called intrinsic value, which is Fulgent Genetics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Fulgent Genetics' market value can be influenced by many factors that don't directly affect Fulgent Genetics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Fulgent Genetics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Fulgent Genetics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Fulgent Genetics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.